NCM · Medical - Diagnostics & Research

bioAffinity Technologies, Inc. (BIAF) Stock

$5.64 -8.44% NCM: BIAF Healthcare

Valuation

MetricValue
Price$5.64
Market Cap$2.36M
P/E Ratio-0.05
P/B Ratio0.56
P/S Ratio0.43
EPS (TTM)$0.00
52-Week High$80.70
52-Week Low$4.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-257.27%
ROA-199.30%
ROCE-250.72%
Gross Margin-183.33%
Operating Margin-183.33%
Net Margin-257.33%
Debt/Equity0.38
Current Ratio2.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$3.0M$9.0M$6.0M
Operating Profit$-2.0M$-4.0M$-8.0M$-9.0M$-11.0M
Net Profit$-6.0M$-8.0M$-8.0M$-9.0M$-15.0M
EPS$-1043.55$-814.50$-409.50$-337.50$-129.90
Op Margin—-83511.5%-314.9%-95.6%-171.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$12.0M$8.0M$7.0M$11.0M
Total Liabilities$17.0M$1.0M$3.0M$4.0M$4.0M
Cash$1.0M$11.0M$3.0M$1.0M$6.0M
Borrowings$11.0M$0$2.0M$2.0M$1.0M

Latest News

bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD Business Wire · Jul 22, 2026 BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell? Zacks · Jul 9, 2026 bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues Business Wire · Jul 7, 2026 Q2 Virtual Investor Summit Presentations Now Available On Demand ACCESS Newswire · Jun 30, 2026 Q2 Investor Summit Virtual Live Wednesday June 24 ACCESS Newswire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-4.0M$-6.0M$-7.0M$-9.0M
Investing Cash Flow$0$0$-2.0M$0$0
Financing Cash Flow$0$8.0M$0$1.0M$0
Net Cash Flow$1.0M$10.0M$-9.0M$-2.0M$5.0M
Free Cash Flow$-2.0M$-4.0M$-6.0M$-7.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.10
FCF Yield-453.41%
Quick Ratio1.41
Interest Coverage-276.15
Return 1Y-91.78%
Return 3Y-98.64%
Return 5Y—

Ownership

Insiders Held2.29%
Institutions Held6.44%
Institutions Float Held6.59%
Institutional HolderSharesReport Date
Vanguard Capital Management LLC55,5432026-03-31
Geode Capital Management, LLC48,2932026-03-31
J. Safra Sarasin Holding AG42,6002026-03-31
Vanguard Fiduciary Trust Co31,0712026-03-31
Schonfeld Strategic Advisors Llc24,4132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARTLArtelo Biosciences, Inc. $3.37 -1.17% -0.05 $1.31M 0.00%
CARMCarisma Therapeutics, Inc. $0.01 -5.17% 0.01 $230148 0.00%
GTBPGT Biopharma, Inc. $5.96 -3.87% -0.06 $7.52M 0.00%
LIPOLipella Pharmaceuticals Inc. $0.07 +0.00% -0.05 $300354 0.00%
MNDRMobile-health Network Solutions $0.82 -8.37% -0.02 $20293 0.00%

About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. is led by CEO Maria Zannes, publicly traded since 2022.

bioAffinity Technologies, Inc. (BIAF) stock trades at $5.64 with a market capitalization of $2.36M. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of 0.56, price-to-sales of 0.43. Over the past 52 weeks the stock has ranged between $4.56 and $80.70, and currently trades 93.0% below its 52-week high.

On profitability, bioAffinity Technologies, Inc. generates a return on equity (ROE) of -257.27%, return on capital employed of -250.72%, an operating margin of -183.33%, a net profit margin of -257.33%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1171.00 +0.12% JNJ Johnson & Johnson $259.44 +1.15% ABBV AbbVie Inc. $275.16 +1.01% MRK Merck & Company, Inc. Common Stock (new) $144.72 +1.64% UNH UnitedHealth Group Incorporated Common Stock (DE) $374.26 +0.89% NVS Novartis AG $143.67 +0.39% AZN AstraZeneca PLC $159.80 +0.64% TMO Thermo Fisher Scientific Inc $654.06 +0.32% AMGN Amgen Inc. $411.01 +0.88% GILD Gilead Sciences, Inc. $148.75 +1.12% ABT Abbott Laboratories $99.36 +0.88% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides